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ABSTRACT 
Objective: This study aimed to test the sensitivity and reproducibility of a multi-sensor 
activity monitor (SWM) in patients with Chronic Obstructive Pulmonary Disease 
(COPD).                                                                                                                 
Background: Activity monitors need to detect slow speeds of walking to be of use in 
patients with COPD.                                                                                                                                        
Methods: 57 COPD patients [mean (SD) age 70.5 (9.3) years, FEV1 60.9 (19.3) % 
predicted, 30 male] completed an incremental shuttle walk test (ISWT) wearing a 
SWM. 20 patients repeated an ISWT wearing the same SWM.                                     
Results:  Sensitivity to detect speed variation: Differences were detected between 
metabolic equivalents (METS) and between step count for levels of the ISWT 
(p<0.001). Reproducibility: Within monitor reproducibility between two ISWT was 
satisfactory for total energy expenditure and step count (p<0.001).                                                                                     
Conclusions: The SWM is able to detect slow (standardised) speeds of walking and is 
an acceptable method for measuring physical activity in individuals disabled by 
COPD.  
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ABBREVIATIONS 
Chronic obstructive pulmonary disease: COPD                                                                         
Coefficient of variance: CV                                                                                            
Endurance shuttle walking test: ESWT                                                                                         
Forced expiratory volume in 1 second: FEV1                                                                    
Forced expiratory volume in 1 second / forced vital capacity: FEV1/FVC ratio                                  
Global Initiative for Obstructive Lung Disease: GOLD                                                                                                     
Incremental shuttle walking test: ISWT                                                                                                                                                                                                                        
Metabolic Equivalents: METS                                                                                                   
Pulmonary Rehabilitation: PR                                                                                                  
Respiratory exchange ratio: RER                                                                                              
The multi-sensor activity monitor (SenseWear PRO2 Armband): SWM                               
Six minute walk test: 6MWT                                                                                           
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INTRODUCTION                                                                                                                                                                                                
 
A reduction in physical activity has been linked with decline in lung function (1), 
hospitalisation (2) and mortality (2;3) in people with chronic obstructive pulmonary 
disease (COPD). There is evidence that habitual physical activity is modifiable by 
interventions such as pulmonary rehabilitation (PR) leading to significant health 
benefits (4). Self-reported assessment of physical activity may be inaccurate in patients 
with COPD (5) and therefore a more objective measurement is desirable.  
 
A device must be able to detect all activity performed by patients to be meaningful. 
The pedometer provides a step count which has been shown to have moderate 
reproducibility in patients with COPD but it may not be as accurate in patients, as it is 
in healthy individuals (6;7). It is possible that the pedometer is not sensitive enough to 
detect the lower intensity movement of the disabled patient (8).  
 
Previous reports have described the use of physical activity monitors to identify brisk 
walking in patients with COPD, as well as in healthy individuals (9-12). Various 
physical activity monitors are commercially available but the multi-sensor activity 
monitor (SenseWear PRO2 Armband) (SWM) (BodyMedia, Pittsburg, US) has 
recently been found to have the greatest validity during standardise physical activity 
(12). However, currently we are still unsure about the sensitivity of this device, 
particularly at detecting steps and energy expenditure at walking speeds less than 
3.27km/h.  
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The SWM has been shown to detect changes in walking speed but speeds were not 
standardised or wide ranging (13;14). The SWM has been described as being a reliable 
and valid way of collecting step and energy expenditure data in patients with COPD 
measured during standard exercise tests; the incremental shuttle walking test (ISWT) 
and the six minute walk test (6MWT) (15). However, due to the cumulative reporting 
of the data it was not confirmed whether the monitors can detect slow speeds of 
walking.  
 
We know patients with COPD sacrifice speed of walking for duration (16). These 
findings confirm the importance of accurately detecting slow speeds of walking in this 
population. Authors have documented concerns about the accuracy of the SWM at 
slower speeds of walking (17). Although the literature suggests that individuals with 
COPD accumulate a much lower number of steps than is recommended we cannot be 
sure whether patients have low levels of activity or if the device failed to detect activity 
at a low intensity (7).  
 
The problem remains that the SWM has not yet been evaluated at slow speeds of 
walking. This is an increasingly popular outcome measure and the robustness of the 
device must be understood to be confident in this outcome. Therefore, the aim of this 
study was to test the sensitivity and reproducibility of the SWM to determine whether 
the device is able to detect slower speeds of walking commonly adopted by individuals 
with COPD.                                                                                                                 
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METHODS                                                                                                                                                                                                
 
Study design 
 
A prospective observational study design was employed. Monitor sensitivity was 
assessed with 57 clinically stable patients with a diagnosis of COPD (forced expiratory 
volume in 1 second (FEV1) < 80% or forced expiratory volume/forced vital capacity 
(FEV1/FVC) ratio < 70% (18). Within monitor reproducibility was assessed with 20 of 
the patients. All patients were eligible for pulmonary rehabilitation, suggesting they 
were disabled by breathlessness and had no physical and psychosocial co-morbidities 
affecting their ability to participate in a walking programme. Patients who were unable 
to complete one level of the ISWT were excluded (19).  
 
 Activity Monitor 
 
The SWM is a commercially available device which estimates energy expenditure 
(Kcal), METS and step count from an accelerometer. The cost is approximately £660 
per monitor and an additional £1000 covers the software required to download data. 
Demographic characteristics (gender, age, height and weight) are required to be 
programmed into the device to estimate energy expenditure using a generalised 
propriety equation (Innerview ® Software Version 5) developed by the manufacturer. 
 
Incremental shuttle walking test [ISWT (19)] 
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The ISWT is an objective test of maximum exercise capacity and requires subjects to 
walk up and down a 10 metre course which is marked out by two cones placed nine 
metres apart. The walking speed is externally paced and dictated by a pre-recorded 
audio signal (a ‘bleep’). There are 12 levels at increasing speeds of walking, each 
levels lasts for one minute. The test is terminated due to symptoms or failure to 
maintain walking speed.  
 
Sample 
 
Fifty seven clinically stable patients with a diagnosis of COPD completed the ISWT 
wearing a SWM. The device is worn halfway between the elbow and the shoulder on 
the back of the right arm. Energy expenditure, METS and step count were recorded 
and only taken from complete shuttle levels walked. Twenty of the patients repeated 
the ISWT wearing the same activity monitor after a 30 minute rest period. The start of 
the ISWT was time stamped to ensure accurate data extraction. For each of the 20 
patients comparisons were made between ISWT one and ISWT two at the end of each 
completed level for both energy expenditure and step count.  
 
Statistical analysis 
 
Sample size was determined by the results from a previous pilot study (n=26) showing 
a difference of approximately 0.5 MET between each level of the ISWT (20). Based on 
these results the study was powered to detect a difference of 0.5 MET between each of 
the five different walking speeds employed in the ISWT. It was calculated that 57 
subjects would be required in total (80% power alpha=0.05). 
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Data was analysed using SPSS version 18.0. An ANOVA with Tukey post hoc 
comparisons assessed the sensitivity of the SWM by detecting differences in METS 
and step count between walking speeds used during the ISWT. 
 
Reproducibility data for the ISWT was assessed using the intra-class correlation 
coefficient (ICC) and the results were plotted using a plot of agreement.  
 
Ethics 
 
All procedures for the experimental methods were approved by Leicestershire, 
Northamptonshire and Rutland Research Ethics Committee 1 (approval no. 
07/Q2501/6) and Coventry University Ethics Committee (approval no. S12.07). 
 
 
RESULTS 
 
Patient characteristics 
 
The characteristics of the patients are presented in Table 1. Fifty seven patients 
completed levels one and two (at 1.8km/h and 2.44km/h respectively) of the ISWT, 55 
completed at level three (3.03km/h), 47 and 37 completed levels four (3.63km/h) and 
five (4.25km/h) respectively. The mean ISWT distance achieved was 343.4m (± 
150.7m (range = 80-660m)). 
 
 
Sensitivity, reproducibility of the SWM 
 9 
Sensitivity to different speeds of walking 
 
Differences were identified between METS and between step count across all five 
levels of the ISWT (METS: F (2,8) = 31.11, p<0.001. Step count: F (2,8) = 117.37, 
p<0.001). A difference of 0.9 METS was found between the slowest speeds of the 
ISWT (1.80km/h + 2.44km/h) (p<0.001). Small and no significant differences were 
detected at the faster speeds (Figure 1). Differences in step count were between all 
speeds (p<0.05) (Figure 2). However in seven of the 57 patients the step count was not 
detected by the device at the slowest speed of walking (1.80km/h). These patients were 
not significantly different in terms of their BMI, FEV1% predicted, age, distance 
walked on the ISWT or MRC dyspnoea grade. 
 
Reproducibility 
 
Good within monitor test-retest reproducibility was demonstrated using the ISWT. The 
ICC was r=0.98 (p<0.001) for the total energy expenditure at the end of each 
completed level (Figure 3) and r=0.94 (p<0.001) for the total step count at the end of 
each completed level.  
 
For information relating to the validity of the device please refer to S1. 
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DISCUSSION 
 
In this study we have reported the sensitivity and reproducibility of the SWM in 
detecting slow speeds of walking. The importance of objective measurement of 
physical activity in patients with COPD is increasingly recognised. For such 
measurements to be accurate in patient populations, the device should be able to 
measure activity at slow speeds of walking. However, authors have expressed concerns 
about the accuracy on the SWM in detecting the slow speeds of walking adopted by the 
disabled patient (8;12;17) 
 
The SWM has been shown to detect changes in different types of physical activity, 
including walking (13). The walking speeds used in the latter study were selected by 
the individual as either fast or slow. These values correspond roughly to levels 4 and 5 
of the ISWT and do not represent a wide range of speeds. More recently Van 
Remoortel and colleagues tested the monitor at a slower walking speed (3.27km/h) but 
this still only equates to level 3 of the ISWT (14). Uniquely we report the sensitivity of 
the monitor at even slower speeds, 1.80km/hr through to 4.25km/hr (levels 1-5 of the 
ISWT) (Figure 2).  
 
Furlanetto et al reported that the SWM was inaccurate at counting steps but accurate at 
estimating energy expenditure. This is in contrast to our study which found step count 
to be more sensitive to change in walking speed (17). During Furlanetto et al’s study 
subjects walked on a treadmill. We believe it is important to test the device during free 
walking on the ground as gait and energy requirements are different during treadmill 
walking (23-25) and may not truly reflect domestic physical activity. Furthermore 
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standardised walking speeds were not applied, making it difficult to conclude if the 
SWM can distinguish between speeds and subjects were only monitored for 1 minute, 
therefore, steady state could not have been reached (17).  
 
Despite the sensitivity of step count, it maybe worth considering that in approximately 
12% of patients step count was not detected at the slowest speed (1.80Km/h). This 
supports previous research which found the SWM to significantly undercount steps 
when compared with a visual step count (21). Combined, these findings highlight the 
importance of reporting multiple variables indicative of physical activity levels.  
 
We have established that the SWM is reproducible in reporting energy expenditure and 
step count at slow speeds of walking, tested during the ISWT. In fact, variability was 
less at lower levels of activity, increasing as energy expenditure reached an excess of 
20Kcal. Patel et al found the SWM to be a reproducible measure of energy expenditure 
during exercise testing in patients with COPD. However, they have reported 
cumulative activity rather than the accuracy of the monitor at slow walking speeds, 
potentially underestimating activity if not all detected (15). 
 
A potential limitation of the study is that the statistical power of the results reduced as 
walking speed increased. As speed increased fewer patients were able to achieve that 
speed (e.g. 3.63Km/hr n=47 and 4.25Km/h n=37). However the particular aim of this 
study was to assess the accuracy of the SWM at slower speeds. We have not compared 
actual step count with step count detected by the monitor. Therefore we can not be 
certain that as speed increases patients are taking more steps, it maybe that the monitor 
is better at capturing the data at faster walking speeds. However, we would expect 
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patients to take more steps at faster speeds as the distance patients cover is increased 
by 10 meters each level of the ISWT.  
 
Whilst accelerometers are still primarily a research tool there has been evidence of the 
clinical use of pedometers (26), and the development of accelerometers within clinical 
services is currently being evaluated (22). Within the context of rehabilitation, the 
devices may have a number of applications. Firstly as an outcome measure but also as 
an aid to exercise prescription and monitoring. A recent review suggests that PR may 
increase physical activity indicating a change in patients behaviour (23). However, in 
order to be confident of these results clinicians need to trust the accuracy of the devices 
used to measure physical activity. It is therefore important to understand the properties 
of the devices at various slow speeds of walking commonly replicated during a 
rehabilitation programme and everyday life. It is not uncommon to prescribe a walking 
programme from performance on the ISWT (24), if we can therefore generate a value 
for energy expenditure and steps at a particular speed we can be more confident in the 
accuracy of the device. 
  
Choosing which accelerometer to use is difficult as a number are currently available 
and each have different strengths and weaknesses depending on the speed of walking 
and the variable measured (11) . The present study supports the use of the SWM after 
evaluating the device in terms of sensitivity and reproducibility at standardised slow 
speeds of walking typical of individuals with COPD. The device is an acceptable 
method for measuring slow standardised speeds of walking and by considering all 
available variables (step count, METS, energy expenditure) it can confidently be used 
in detecting and describing physical activity at slow speeds in patients with COPD. 
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FIGURE LEGENDS 
 
Figure 1. Mean METS for each walking speed of the ISWT. 
 
Figure 2. Mean steps for each walking speed of the ISWT. 
 
Figure 3. The differences in total EE at iso work between ISWT 1 and 2. 1 patient 
completed up to level 1 only, 1 patient completed up to level 2, 4 patients completed 
up to level 3, 2 patients completed up to level 4, 12 patients completed up to level 5. 
The solid line demonstrates mean difference (0.87). The dotted lines represent +/- 2 SD 
from the mean difference (+5.57, -3.83). 
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2.8 (1-5) ~ MRC 1 (n=2) 
          2 (n=23) 
          3 (n=17) 
          4 (n=13) 
          5 (n=2) 
343.4 (150.7) ISWT (m) 
26.8 (5.9) BMI (Kg/m2) 
60.9 (19.3) FEV1 % Predicted  
1.5 (0.6) FEV1 (l) 
70.5 (9.3) Age (years) 
57 (30 male) # n 
Mean (SD)  
FEV1 = forced expiratory volume in 1 second; BMI = body mass index;  
MRC = Medical Research Council. 
# = actual values, ~ = median (IQR) 
Table 1.  Patients’ demographics 



